Extract from the Register of European Patents

EP About this file: EP1863458

EP1863458 - SOLVENT SYSTEM FOR ENHANCING THE SOLUBILITY OF PHARMACEUTICAL AGENTS [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  28.01.2022
Database last updated on 09.04.2026
Most recent event   Tooltip28.01.2022Patent maintained (B2 publication)published on 02.03.2022  [2022/09]
Applicant(s)For all designated states
Patheon Softgels Inc.
4125 Premier Drive
High Point, NC 27265 / US
[2022/09]
Former [2017/50]For all designated states
Patheon Softgels Inc.
4125 Premier Drive
High Point, NC 27265 / US
Former [2016/37]For all designated states
Banner Life Sciences, LLC
4125 Premier Drive
High Point, North Carolina 27265 / US
Former [2015/12]For all designated states
Banner Life Sciences LLC
4125 Premier Drive
High Point, North Carolina 27265 / US
Former [2007/50]For all designated states
Banner Pharmacaps Inc.
4125 Premier Drive
High Point, NC 27265-8144 / US
Inventor(s)01 / CHIDAMBARAM, Nachiappan
8410 Handcart Circle
Sandy, Utah 84070 / US
02 / FATMI, Aqeel
3809 Camden Falls Court
Greensboro, North Carolina 27410 / US
 [2016/37]
Former [2007/50]01 / CHIDAMBARAM, Nachiappan
4001 River Pointe Place, Apt. 3d
High Point, North Carolina 27265 / US
02 / FATMI, Aqeel
3809 Camden Falls Court
Greensboro, North Carolina 27410 / US
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2022/09]
Former [2016/37]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2013/37]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham
NG1 5GG / GB
Former [2007/50]Crowhurst, Charlotte Waveney
Eric Potter Clarkson LLP Park View House 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date06737018.906.03.2006
[2007/50]
WO2006US07788
Priority number, dateUS20050659679P08.03.2005         Original published format: US 659679 P
[2007/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006096580
Date:14.09.2006
Language:EN
[2006/37]
Type: A1 Application with search report 
No.:EP1863458
Date:12.12.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.2006 takes the place of the publication of the European patent application.
[2007/50]
Type: B1 Patent specification 
No.:EP1863458
Date:14.09.2016
Language:EN
[2016/37]
Type: B2 New European patent specification 
No.:EP1863458
Date:02.03.2022
Language:EN
[2022/09]
Search report(s)International search report - published on:EP14.09.2006
ClassificationIPC:A61K9/48
[2007/50]
CPC:
A61K31/192 (EP,US); A61K31/765 (EP,US); A61K47/12 (EP,US);
A61K9/0053 (US); A61K9/4825 (US); A61K9/4833 (US);
A61K9/4858 (EP,US); A61K9/4866 (EP,US); A61K9/50 (US);
A61K9/5089 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/37]
Former [2007/50]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:LÖSUNGSMITTELSYSTEM ZUR ERHÖHUNG DER LÖSLICHKEIT PHARMAZEUTISCHER WIRKSTOFFE[2007/50]
English:SOLVENT SYSTEM FOR ENHANCING THE SOLUBILITY OF PHARMACEUTICAL AGENTS[2007/50]
French:SYSTEME DE SOLVANT DESTINE A AMELIORER LA SOLUBILITE DES AGENTS PHARMACEUTIQUES[2007/50]
Entry into regional phase27.09.2007National basic fee paid 
27.09.2007Designation fee(s) paid 
27.09.2007Examination fee paid 
Examination procedure08.01.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.09.2007Amendment by applicant (claims and/or description)
27.09.2007Examination requested  [2007/50]
20.11.2008Despatch of a communication from the examining division (Time limit: M04)
18.03.2009Reply to a communication from the examining division
29.11.2011Despatch of communication that the application is refused, reason: substantive examination {1}
16.01.2015Despatch of a communication from the examining division (Time limit: M04)
08.05.2015Reply to a communication from the examining division
18.11.2015Communication of intention to grant the patent
17.03.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.03.2016Fee for grant paid
17.03.2016Fee for publishing/printing paid
23.05.2016Communication of intention to grant the patent
30.06.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
05.08.2016Information about intention to grant a patent
05.08.2016Receipt of the translation of the claim(s)
28.06.2018Observations by third parties
Appeal following examination27.01.2012Appeal received No.  T0826/12
26.03.2012Statement of grounds filed
16.09.2014Result of appeal procedure: remittal for grant
16.09.2014Date of oral proceedings
09.10.2014Minutes of oral proceedings despatched
Divisional application(s)EP16163757.4  / EP3061447
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.11.2008
Opposition(s)Opponent(s)01  14.06.2017  20.06.2017  ADMISSIBLE
Dieckhoff, Beate
Dünnwalder Grenzweg 20
51375 Leverkusen / DE
Opponent's representative
Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Postfach 18 04 09
40571 Düsseldorf / DE
 [N/P]
Former [2018/41]
Opponent(s)01  14.06.2017  20.06.2017  ADMISSIBLE
Dieckhoff, Beate
Dünnwalder Grenzweg 20
51375 Leverkusen / DE
Opponent's representative
Gille Hrabal
Postfach 18 04 09
40571 Düsseldorf / DE
Former [2017/30]
Opponent(s)01  14.06.2017  20.06.2017  ADMISSIBLE
Dieckhoff, Beate
Dünnwalder Grenzweg 20
51375 Leverkusen / DE
Opponent's representative
Lohmanns, Bernard
Benrather Schlossallee 49-53
40597 Düsseldorf / DE
20.07.2017Invitation to proprietor to file observations on the notice of opposition
28.11.2017Reply of patent proprietor to notice(s) of opposition
08.11.2018Date of oral proceedings
18.12.2018Despatch of interlocutory decision in opposition
18.12.2018Despatch of minutes of oral proceedings
11.11.2021Legal effect of interlocutory decision in opposition
29.11.2021Despatch of communication that the patent will be maintained as amended
20.01.2022Fee for printing new specification paid
Appeal following opposition15.02.2019Appeal received No.  T0492/19
16.04.2019Statement of grounds filed
11.11.2021Result of appeal procedure: appeal of the proprietor withdrawn
25.02.2019Appeal received No.  T0492/19
11.11.2021Result of appeal procedure: appeal of the proprietor withdrawn
11.11.2021Date of oral proceedings
Fees paidRenewal fee
27.09.2007Renewal fee patent year 03
13.03.2009Renewal fee patent year 04
15.03.2010Renewal fee patent year 05
15.03.2011Renewal fee patent year 06
14.03.2012Renewal fee patent year 07
11.03.2013Renewal fee patent year 08
12.03.2014Renewal fee patent year 09
10.03.2015Renewal fee patent year 10
10.03.2016Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD] US5360615  (YU MAN S et al.) [XD] 1-31 * example 8 *
 [X] WO9531979  (R P SCHERER INTERNATIONAL CORP et al.) [X] 1-31 * page 4, line 1 - line 10 * * example 8 *
 [X] US2001007668  (SAWYER MARYJEAN et al.) [X] 1-31 * paragraph [0061]; tables 1-17 *
 [X] US5484606  (DHABHAR DADI J et al.) [X] 1-31 * example - *
 [A] US5912011  (MAKINO HIROKAZU et al.) [A] 1-31 * tables 2,3 *
 [A] US2004157928  (KIM JAE-HWAN et al.) [A] 1-31 * tables 5c,5d * * paragraph [0005] *
otherUS5360615
 US2004157928
 US6383471
 WO0059475
   ROBERT THORNTON MORRISON, ROBERT NEILSON BOYD: "Organic Chemistry, Fourth Edition", 1983, ALLYN AND BACON INC., pages: 3pp, 787, XP055497013
   RAYMOND C ROWE, PAUL J SHESKEY, MARIAN E QUINN: "Handbook of Pharmaceutical Excipients, Sixth Edition", 2009, PHARMACEUTICAL PRESS, article "Lactic Acid", pages: 4pp, 355 - 356, XP055497017
OppositionUS5360615
 WO2006096580
 US2001007668
 US5541210
 US2004157928
   "Experiments to Test the Stability of Compositions of the Invention Against Formation of PEG Esters", BANNER PHARMACAPS, INC., 16 September 2011 (2011-09-16), pages 1 - 5, XP055392403
   "REPORT OF COMPARATIVE STUDIES CONDUCTED TO COMPARE THEPROPERTIES OF COMPOSITIONS OBTAINED IN ACCORDANCE WITH THEINVENTION AND THE COMPOSITIONS DESCRIBED IN US 5,360,615", BANNER PHARMACAPS, INC, 26 March 2012 (2012-03-26), pages 1 - 8, XP055392405
   BEYER WALTER: "Lehrbuch der organischen Chemie", 1988, Stuttgart , Hirzel, article "2.29 Substitutionsprodukte aliphatischer Monocarbonsauren", pages: 280, XP055392407
   "Milchsure", WIKIPEDIA, 24 May 2017 (2017-05-24), pages 1 - 6, XP055392408
   BEYER WALTER: "Lehrbuch der organischen Chemie", 1988, Stuttgart , Hirzel, article "2.28 Derivate aliphatischer Monocarbonsauren", pages: 260, XP055392413
   "citric acid", WIKIPEDIA, 6 June 2017 (2017-06-06), pages 1 - 8, XP055392415
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.